- Home
- MIN vs SOPH Comparison
MIN vs SOPH Comparison
Compare MIN & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIN
- SOPH
- Stock Information
- Founded
- MIN 1988
- SOPH 2011
- Country
- MIN United States
- SOPH Switzerland
- Employees
- MIN N/A
- SOPH N/A
- Industry
- MIN Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MIN Finance
- SOPH Health Care
- Exchange
- MIN Nasdaq
- SOPH Nasdaq
- Market Cap
- MIN 307.4M
- SOPH 231.8M
- IPO Year
- MIN N/A
- SOPH 2021
- Fundamental
- Price
- MIN $2.69
- SOPH $3.23
- Analyst Decision
- MIN
- SOPH
- Analyst Count
- MIN 0
- SOPH 0
- Target Price
- MIN N/A
- SOPH N/A
- AVG Volume (30 Days)
- MIN 331.0K
- SOPH 38.8K
- Earning Date
- MIN 01-01-0001
- SOPH 11-04-2025
- Dividend Yield
- MIN 7.31%
- SOPH N/A
- EPS Growth
- MIN N/A
- SOPH N/A
- EPS
- MIN 0.08
- SOPH N/A
- Revenue
- MIN N/A
- SOPH $69,688,000.00
- Revenue This Year
- MIN N/A
- SOPH $16.60
- Revenue Next Year
- MIN N/A
- SOPH $18.77
- P/E Ratio
- MIN $33.38
- SOPH N/A
- Revenue Growth
- MIN N/A
- SOPH 7.32
- 52 Week Low
- MIN $2.52
- SOPH $2.58
- 52 Week High
- MIN $2.88
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- MIN 48.57
- SOPH 46.63
- Support Level
- MIN $2.67
- SOPH $3.10
- Resistance Level
- MIN $2.73
- SOPH $3.49
- Average True Range (ATR)
- MIN 0.02
- SOPH 0.16
- MACD
- MIN -0.00
- SOPH -0.02
- Stochastic Oscillator
- MIN 33.33
- SOPH 31.71
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.